Skip to main content
Premium Trial:

Request an Annual Quote

Like Office, But for Bioresearch

At the Bio-IT conference this week, Microsoft introduced Amalga Life Sciences, according to Bio-IT World. Amalga is part of Microsoft's "plan create a single information highway and data aggregation/modeling platform that spans basic research, clinical trials, health care delivery, and consumer health information needs." With this Microsoft will be targeting academic medical centers, biotechs, and pharma. Consider yourself warned.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.